Literature DB >> 1523047

Plain film and CT observations in prostaglandin-induced bone changes.

M A Matzinger1, V A Briggs, H J Dunlap, K Udjus, D J Martin, P McDonald.   

Abstract

Prostaglandin E1 intravenous infusion is used in infants with ductal-dependent congenital heart disease to maintain ductal patency and prolong life until palliative or corrective surgery is feasible. Complications of prostaglandin administration include fever, diarrhoea, hypotension, apnoea, bradycardia, pseudowidening of the cranial sutures, underossification of the calvarial bones, periostitis, and skin edema [1-3]. This paper presents dramatic plain radiographic features of prostaglandin-induced bone disease, including periosteal proliferation and the unusual bone-within-bone appearance, and provides the previously unpublished CT correlation.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1523047     DOI: 10.1007/bf02019854

Source DB:  PubMed          Journal:  Pediatr Radiol        ISSN: 0301-0449


  11 in total

1.  Prostaglandin-induced periostitis: a complication of long-term PGE1 infusion in an infant with congenital heart disease.

Authors:  R E Ringel; J I Brenner; P J Haney; J E Burns; A L Moulton; M A Berman
Journal:  Radiology       Date:  1982-03       Impact factor: 11.105

2.  Periosteal changes secondary to prostaglandin administration.

Authors:  R E Ringel; P J Haney; J I Brenner; T J Mancuso; G S Roberts; A L Moulton; M A Berman
Journal:  J Pediatr       Date:  1983-08       Impact factor: 4.406

3.  Cortical hyperostosis following long-term administration of prostaglandin E1 in infants with cyanotic congenital heart disease.

Authors:  K Ueda; A Saito; H Nakano; M Aoshima; M Yokota; R Muraoka; T Iwaya
Journal:  J Pediatr       Date:  1980-11       Impact factor: 4.406

4.  Long-term low-dose prostaglandin E1 administration.

Authors:  K Sone; M Tashiro; T Fujinaga; T Tomomasa; K Tokuyama; T Kuroume
Journal:  J Pediatr       Date:  1980-11       Impact factor: 4.406

5.  Widening of cranial sutures after long-term prostaglandin E2 therapy in two newborn infants.

Authors:  H Hoevels-Guerich; L Haferkorn; M Persigehl; R Hofstetter; G von Bernuth
Journal:  J Pediatr       Date:  1984-07       Impact factor: 4.406

6.  Soft-tissue swelling in two neonates during prostaglandin E1 therapy.

Authors:  S Jureidini; N A Chase; B S Alpert; T Vanderzalm; R E Sheneflet
Journal:  Pediatr Cardiol       Date:  1986       Impact factor: 1.655

7.  Bone formation induced in an infant by systemic prostaglandin-E2 administration.

Authors:  H R Jørgensen; H Svanholm; A Høst
Journal:  Acta Orthop Scand       Date:  1988-08

8.  Pseudo-widening of cranial sutures as a feature of long-term prostaglandin E1 therapy.

Authors:  A Beitzke; J Stein
Journal:  Pediatr Radiol       Date:  1986

9.  Prostaglandin-induced hyperostosis. A case report.

Authors:  D M Drvaric; W J Parks; J B Wyly; K J Dooley; W H Plauth; E W Schmitt
Journal:  Clin Orthop Relat Res       Date:  1989-09       Impact factor: 4.176

10.  Bone changes from prostaglandin therapy.

Authors:  A K Poznanski; S K Fernbach; T E Berry
Journal:  Skeletal Radiol       Date:  1985       Impact factor: 2.199

View more
  1 in total

1.  Cortical hyperostosis simulating osteomyelitis after short-term prostaglandin E1 infusion.

Authors:  A K Kalloghlian; H H Frayha; M M deMoor
Journal:  Eur J Pediatr       Date:  1996-03       Impact factor: 3.183

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.